KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.79M	-
CFO	Gall Matthew	235.0K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 18, 2022	Brainard Diana85	Chief Executive Officer	Sell	4,564	$7.76	$35,428.51	-0.7%	-3.8%	-63.7%
Aug 16, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	15,590	$8.30	$129,473.39	-3.9%	+3.2%	-68.0%
Jul 21, 2022	Atillasoy Ercem78	See Remarks	Sell	1,533	$5.38	$8,245.09	-1.1%	+78.8%	-33.7%
Jul 21, 2022	Hallal David79	Director, 10% Owner	Sell	4,227	$5.33	$22,527.80	-0.2%	+78.8%	-33.7%
Jul 20, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	1,058	$5.21	$5,516.94	-0.3%	+87.2%	-37.9%
Jul 20, 2022	Sinha Vikas84	See Remarks	Sell	1,432	$5.21	$7,467.16	-0.2%	+87.2%	-37.9%
Jul 20, 2022	Atillasoy Ercem78	See Remarks	Sell	563	$5.21	$2,935.76	-0.4%	+87.2%	-37.9%
Jun 3, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	515	$3.63	$1,870.53	-0.1%	+102.7%	+7.0%
Jun 3, 2022	Hallal David79	Director, 10% Owner	Sell	65,725	$3.67	$241,105.59	-3.1%	+102.7%	+7.0%
May 18, 2022	Brainard Diana85	Chief Executive Officer	Sell	29,135	$4.33	$126,256.52	-5.6%	+89.8%	-4.6%

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC